Interacting Drugs |
Ketoconazole (systemic) vs Colchicine |
Security Level |
![]() |
Mechanism |
Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased. |
Management |
Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor. In those with normal renal and hepatic function, reduce colchicine dose as directed. |
Ketoconazole (systemic) vs Colchicine
Post Review about Ketoconazole (systemic) vs Colchicine Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Colchicine
Ketoconazole (systemic) vs Colchicine
Interacting Drugs |
Ketoconazole (systemic) vs Colchicine |
Security Level |
![]() |
Mechanism |
Colchicine: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Colchicine. |
Management |
Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a strong CYP3A4 inhibitor. In those with normal renal and hepatic function, reduce colchicine dose as directed. |
No comments yet.
Post Review about Ketoconazole (systemic) vs Colchicine Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Colchicine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.